Loading Doses for Clopidogrel and Aspirin in Elderly Patients with NSTEMI

Aspirin Loading Dose

The American College of Cardiology recommends administering 162-325 mg of non-enteric-coated, chewable aspirin immediately upon presentation to patients with NSTEMI, including those who are already on aspirin therapy, with a preferred maintenance dose of 81 mg daily when combined with P2Y12 inhibitors 1, 2
The aspirin must be chewable and non-enteric-coated to avoid delayed absorption, and this loading dose applies regardless of whether the patient is already on aspirin therapy 1, 2

The American College of Cardiology recommends that in patients over 75 years old, no loading dose of clopidogrel should be given, and instead, start directly with 75 mg daily maintenance dose, due to bleeding concerns 3
Advanced age (≥80 years) is identified as a major risk factor for bleeding under antiplatelet therapy, and patients over 75 years were specifically excluded from loading dose protocols in major trials due to bleeding concerns 3, 4

For patients 75 years or younger, the standard approach would be a clopidogrel 300-600 mg loading dose, followed by 75 mg daily maintenance, although this may vary based on individual patient risk factors 1, 2

The American College of Cardiology recommends continuing dual antiplatelet therapy (aspirin + clopidogrel) for at least 12 months unless bleeding risk outweighs benefit, with regular assessment of bleeding risk factors 1, 2

The American College of Cardiology recommends calculating the PRECISE-DAPT score to assess bleeding risk, and considering shortened DAPT duration (≤6 months) if score ≥25, as well as evaluating for absolute contraindications and checking renal function 4

While ticagrelor is generally preferred over clopidogrel in NSTEMI, the same age-related bleeding concerns apply, and careful risk-benefit assessment is essential in elderly patients, with consideration of alternative therapies and dosing regimens 1, 2

The American College of Cardiology recommends avoiding enteric-coated aspirin initially, as it has delayed and reduced absorption, and not giving standard loading doses of clopidogrel to patients over 75 years, as this significantly increases bleeding risk 1, 2, 3
High-dose aspirin maintenance (≥160 mg) is associated with increased bleeding without improved outcomes, and triple therapy (aspirin + clopidogrel + anticoagulant) should be avoided if possible, with limitation to 1-6 months maximum if required 2, 4